391
Views
13
CrossRef citations to date
0
Altmetric
Review

Mathematical models for dermal drug absorption

, & (Professor)

Bibliography

  • European Parliament CotEU. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency. 2006
  • OECD. Guidance document for the conduct of skin absorption studies. OECD Publishing; Paris: 2004
  • OECD. Test No. 428: skin Absorption: In Vitro Method. OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris; 2004
  • World Health Organization. Dermal Absorption (EHC 235). 2006
  • Anissimov YG, Jepps OG, Dancik Y, et al. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes. Adv Drug Deliv Rev 2013;65(2):169-90
  • Yamashita F, Hashida M. Mechanistic and empirical modeling of skin permeation of drugs. Adv Drug Deliv Rev 2003;55(9):1185-99
  • Crank J. The mathematics of diffusion. Oxford University Press; London: 1975
  • Frasch F, Barbero AM. Application of numerical methods for diffusion-based modeling of skin permeation. Adv Drug Deliv Rev 2013;65(2):208-20
  • McCarley KD, Bunge AL. Pharmacokinetic models of dermal absorption. J Pharm Sci 2001;90(11):1699-719
  • Seta Y, Ghanem AH, Higuchi WI, et al. Physical model approach to understanding finite dose transport and uptake of hydrocortisone in hairless guinea-pig skin. Int J Pharm 1992;81(1):89-99
  • Guy RH, Hadgraft J. Transdermal drug delivery: A simplified pharmacokinetic approach. Int J Pharm 1985;24(2-3):267-74
  • Wallace SM, Barnett G. Pharmacokinetic analysis of percutaneous absorption: evidence of parallel penetration pathways for methotrexate. J Pharmacokinet Biopharm 1978;6(4):315-25
  • Hansen S, Lehr C-M, Schaefer UF. Improved input parameters for diffusion models of skin absorption. Adv Drug Deliv Rev 2013;65(2):251-64
  • Guy R, Hadgraft J, Maibach H. A pharmacokinetic model for percutaneous absorption. Int J Pharm 1982;11(2):119-29
  • Kubota K. A compartment model for percutaneous drug absorption. J Pharm Sci 1991;80(5):502-4
  • Davies M, Pendlington RU, Page L, et al. Determining epidermal disposition kinetics for use in an integrated nonanimal approach to skin sensitization risk assessment. Toxicol Sci 2011;119(2):308-18
  • Polak S, Ghobadi C, Mishra H, et al. Prediction of concentration–time profile and its inter-individual variability following the dermal drug absorption. J Pharm Sci 2012;101(7):2584-95
  • McCarley K, Bunge A. Physiologically relevant two-compartment pharmacokinetic models for skin. J Pharm Sci 2000;89(9):1212-35
  • Reddy M, McCarley K, Bunge A. Physiologically relevant one-compartment pharmacokinetic models for skin. 2. Comparison of models when combined with a systemic pharmacokinetic model. J Pharm Sci 2000;87(4):482-90
  • Knofczynski GT, Mundfrom D. Sample sizes when using multiple linear regression for prediction. Educ Psychol Meas 2008;68(3):431-42
  • Wehrens R, Putter H, Buydens LMC. The bootstrap: a tutorial. Chemom Intell Lab Syst 2000;54(1):35-52
  • Tropsha A, Gramatica P, Gombar VK. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 2003;22(1):69-77
  • Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992;9(5):663-9
  • Flynn GL. Physicochemical determinants of skin absorption. In: Gerrity TR, Henry CJ, editors. Principles of Route-to-Route Extrapolation for Risk Assessment, Elsevier; New York: 1990. pp. 93-127
  • Wilschut A, ten Berge WF, Robinson PJ, et al. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995;30(7):1275-96
  • Patel H, Berge WT, Cronin MTD. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere 2002;48(6):603-13
  • Roberts MS, Pugh WJ, Hadgraft J. Epidermal permeability: Penetrant structure relationships. Int J Pharm 1996;132(1-2):23-32
  • Pugh WJ, Roberts MS, Hadgraft J. Epidermal permeability-penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int J Pharm 1996;138(2):149-65
  • Pugh WJ, Degim IT, Hadgraft J. Epidermal permeability-penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. Int J Pharm 2000;197(1-2):203-11
  • Brown MB, Lau C-H, Lim ST, et al. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption. J Pharm Pharmacol 2012;64(4):566-77
  • Değím T, Hadgraft J, Ilbasmiş S, et al. Prediction of skin penetration using artificial neural network (ANN) modeling. J Pharm Sci 2003;92(3):656-64
  • Fatemi MH, Malekzadeh H. In silico prediction of dermal penetration rate of chemicals from their molecular structural descriptors. Environ Toxicol Pharmacol 2012;34(2):297-306
  • Lim CW, Fujiwara S-I, Yamashita F, et al. Prediction of Human Skin Permeability Using a Combination of Molecular Orbital Calculations and Artificial Neural Network. Biol Pharm Bull 2002;25(3):361-6
  • Neely BJ, Madihally SV, Robinson RL, et al. Nonlinear quantitative structure-property relationship modeling of skin permeation coefficient. J Pharm Sci 2009;98(11):4069-84
  • Neumann D, Kohlbacher O, Merkwirth C, et al. A Fully Computational Model for Predicting Percutaneous Drug Absorption. J Chem Inf Model 2006;46(1):424-9
  • Ghafourian T, Zandasrar P, Hamishekar H, et al. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Controlled Release 2004;99(1):113-25
  • Zheng T, Hopfinger AJ, Esposito EX, et al. Membrane-Interaction Quantitative Structure−Activity Relationship (MI-QSAR) Analyses of Skin Penetration Enhancers. J Chem Inf Model 2008;48(6):1238-56
  • Ghafourian T, Samaras EG, Brooks JD, et al. Validated models for predicting skin penetration from different vehicles. Eur J Pharm Sci 2010;41(5):612-16
  • Karadzovska D, Brooks JD, Monteiro-Riviere NA, et al. Predicting skin permeability from complex vehicles. Adv Drug Delivery Rev 2013;65(2):265-77
  • Magnusson BM, Anissimov YG, Cross SE, et al. Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 2004;122(4):993-9
  • Zhang Q, Grice JE, Li P, et al. Skin solubility determines maximum transepidermal flux for similar size molecules. Pharm Res 2009;26(8):1974-85
  • Milewski M, Stinchcomb AL. Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants. Mol Pharm 2012;9(7):2111-20
  • Frasch HF, Barbero AM, Hettick JM, et al. Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin. J Pharm Sci 2011;100(7):2989-95
  • Guy RH, Hadgraft J, Bucks DAW. Transdermal drug delivery and cutaneous metabolism. Xenobiotica 1987;17(3):325-43
  • Reddy MB, Guy RH, Bunge AL. Does epidermal turnover reduce percutaneous penetration? Pharm Res 2000;17(11):1414-19
  • Dancik Y, Anissimov YG, Jepps OG. Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application. Brit J Clin Pharmaco 2012;73(4):564-78
  • Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 3. Variable Diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. J Pharm Sci 2004;93(2):470-87
  • Einstein A. Über die von der molekularkinetischen Theorie der Wärme geforderte Bewegung von in ruhenden Flüssigkeiten suspendierten Teilchen. Annalen der Physik 1905;322(8):549-60
  • Anderson BD, Raykar PV. Solute structure-permeability relationships in human stratum corneum. J Invest Dermatol 1989;93(2):280-6
  • Anderson BD, Higuchi WI, Raykar PV. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm Res 1988;5(9):566-73
  • Beezer AE, Gooch CA, Hunter WH, et al. A thermodynamic analysis of the Collander equation and establishment of a reference solvent for use in drug partitioning studies. J Pharm Pharmacol 1987;39(10):774-9
  • Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967;48(1):79-88
  • Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: Theory and in vitro experimental measurement. AIChE J 1975;21(5):985-96
  • Sloan KB, Wasdo SC, Rautio J. Design for optimized topical delivery: Prodrugs and a paradigm change. Pharm Res 2006;23(12):2729-47
  • Zhang Q, Li P, Roberts MS. Maximum transepidermal flux for similar size phenolic compounds is enhanced by solvent uptake into the skin. J Control Release 2011;154(1):50-7
  • Fiserova-Bergerova V, Pierce JT, Droz PO. Dermal absorption potential of industrial chemicals: Criteria for skin notation. Am J Ind Med 1990;17(5):617-35
  • McKone TE, Howd RA. Estimating dermal uptake of nonionic organic chemicals from water and soil: I. Unified fugacity-based models for risk assessments. Risk Anal 1992;12(4):543-57
  • Winckle G, Anissimov YG, Cross SE, et al. An integrated pharmacokinetic and imaging evaluation of vehicle effects on solute human epidermal flux and, retention characteristics. Pharm Res 2008;25(1):158-66
  • Schäfer-Korting M, Bock U, Diembeck W, et al. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. ATLA-Altern Lab Anim 2008;36(2):161-87
  • OECD. Guidance document on the validation of (Q)SAR models. OECD Environment Health and Safety Publications; Paris: 2007
  • Barbero AM, Frasch F. Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicol In Vitro 2009;23(1):1-13
  • Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. J Pharm Sci 1999;88(11):1201-9
  • Buist HE, van Burgsteden JA, Freidig AP, et al. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharm 2010;57(2-3):200-9
  • Díez-Sales O, Copovicí A, Casabó VG, et al. A modelistic approach showing the importance of the stagnant aqueous layers in in vitro diffusion studies, and in vitro-in vivo correlations. Int J Pharm 1991;77(1):1-11
  • Kubota K, Koyama E, Twizell EH. Dual sorption model for the nonlinear percutaneous kinetics of timolol. J Pharm Sci 1993;82(12):1205-8
  • Henning A, Schaefer UF, Neumann D. Potential pitfalls in skin permeation experiments: Influence of experimental factors and subsequent data evaluation. Eur J Pharm Biopharm 2009;72(2):324-31
  • Carslaw HS, Jaeger JC. Conduction of heat in solids. Clarendon Press; Oxford: 1959
  • Cooper ER, Berner B. Finite dose pharmacokinetics of skin penetration. J Pharm Sci 1985;74(10):1100-2
  • Kasting GB. Kinetics of finite dose absorption through skin 1. Vanillylnonanamide. J Pharm Sci 2001;90(2):202-12
  • Brent RP. Algorithms for minimization without derivatives. Prentice-Hall; Englewood Cliffs: 1973
  • Scheuplein RJ, Ross LW. Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 1974;62(4):353-60
  • van de Sandt JJM, van Burgsteden JA, Cage S, et al. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharm 2004;39(3):271-81
  • Wilkinson SC, Maas WJM, Nielsen JB, et al. Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies. Int Arch Occ Env Hea 2006;79(5):405-13
  • Hahn T, Selzer D, Neumann D, et al. Influence of the application area on finite dose permeation in relation to drug type applied. Exp Dermatol 2012;21(3):233-5
  • Selzer D, Hahn T, Naegel A, et al. Finite dose skin mass balance including the lateral part: Comparison between experiment, pharmacokinetic modeling and diffusion models. J Control Release 2013;165(2):119-28
  • Kasting GB, Miller MA. Kinetics of finite dose absorption through skin 2: Volatile compounds. J Pharm Sci 2006;95(2):268-80
  • Frasch HF, Barbero AM. The transient dermal exposure: Theory and experimental examples using skin and silicone membranes. J Pharm Sci 2008;97(4):1578-92
  • Frasch HF, Bunge AL, The Transient Dermal Exposure II. Post-Exposure Absorption and Evaporation of Volatile Compounds. J Pharm Sci 2015;104(4):1499-507
  • Guy RH, Hadgraft J. Percutaneous metabolism with saturable enzyme kinetics. Int J Pharm 1982;11(3):187-97
  • Hadgraft J. The epidermal reservoir; A theoretical approach. Int J Pharm 1979;2(5-6):265-74
  • Hadgraft J. Theoretical aspects of metabolism in the epidermis. Int J Pharm 1980;4(3):229-39
  • Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 2001;90(4):504-20
  • Anissimov YG, Roberts MS. Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics. J Pharm Sci 2009;98(2):772-81
  • Simon L, Goyal A. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover. J Pharm Sci 2009;98(1):187-204
  • Anissimov YG, Watkinson A. Modelling Skin Penetration Using the Laplace Transform Technique. Skin Pharmacol Physiol 2013;26(4-6):286-94
  • Melero A, Hahn T, Schaefer UF, et al. In vitro human skin segmentation and drug concentration-skin depth profiles. Turksen K, edition Permeability barrier. 2 edition. Humana Press; New York: 2011. 33-50
  • Stinchcomb AL, Pirot F, Touraille GD, et al. Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm Res 1999;16(8):1288-93
  • Wagner H, Kostka KH, Lehr CM, et al. Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject. J Investig Dermatol 2002;118(3):540-4
  • Löffler H, Dreher F, Maibach HI. Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol 2004;151(4):746-52
  • Lademann J, Jacobi U, Surber C, et al. The tape stripping procedure – evaluation of some critical parameters. Eur J Pharm Biopharm 2009;72(2):317-23
  • Escobar-Chavez JJ, Merino-Sanjuan V, Lopez-Cervantes M, et al. The Tape-Stripping Technique as a Method for Drug Quantification in Skin. J Pharm Pharm Sci 2008;11(1):104-30
  • Lademann J, Jacobi U, Surber C, et al. The tape stripping procedure - evaluation of some critical parameters. Eur J Pharm Biopharm 2009;72(2):317-23
  • Naegel A, Hansen S, Neumann D, et al. In-silico model of skin penetration based on experimentally determined input parameters. Part II: Mathematical modelling of in-vitro diffusion experiments. Identification of critical input parameters. Eur J Pharm Biopharm 2008;68(2):368-79
  • Naegel A, Hahn T, Schaefer U, et al. Finite dose skin penetration: a comparison of concentration-depth profiles from experiment and simulation. Comput Visual Sci 2011;14(7):327-39
  • Herkenne C, Naik A, Kalia YN, et al. Ibuprofen transport into and through skin from topical formulations: In vitro-in vivo comparison. J Invest Dermatol 2006;127(1):135-42
  • Shah VP, Flynn GL, Yacobi A, et al. AAPS/FDA Workshop Report: Bioequivalence of topical dermatological dosage forms: Methods of evaluation of bioequivalence. Advanstar Communications; Duluth, MN, ETATS-UNIS: 1998
  • Wearley LL, Tojo K, Chien YW. A numerical approach to study the effect of binding on the iontophoretic transport of a series of amino acids. J Pharm Sci 1990;79(11):992-8
  • Kurnik RT, Potts RO. Modeling of diffusion and crystal dissolution in controlled release systems. J Control Release 1997;45(3):257-64
  • Kubota K, Dey F, Matar SA, et al. A repeated-dose model of percutaneous drug absorption. Appl Math Model 2002;26(4):529-44
  • George K. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption. Biomed Eng Online 2005;4:40
  • Hansen S, Naegel A, Heisig M, et al. The role of corneocytes in skin transport revised - a combined computational and experimental approach. Pharm Res 2009;26:1379-97
  • Muha I, Naegel A, Stichel S, et al. Effective diffusivity in membranes with tetrakaidekahedral cells and implications for the permeability of human stratum corneum. J Membrane Sci 2010;368(1-2):18-25
  • Fort ECD, Frankel SP. Stability Conditions in the Numerical Treatment of Parabolic Differential Equations. Math Tables Other Aids Comput 1953;7(43):135-52
  • Crank J, Nicolson P. A practical method for numerical evaluation of solutions of partial differential equations of the heat-conduction type. Mathematical Proc Cambridge Philosophical Soc 1947;43:50-67
  • Douglas J. Jr. The solution of the heat equation by a high order correct difference equation. J Math Phys 1956;35:145-51
  • Nitsche JM, Frasch HF. Dynamics of diffusion with reversible binding in microscopically heterogeneous membranes: General theory and applications to dermal penetration. Chem Eng Sci 2011;66(10):2019-41
  • Barbero AM, Frasch HF. Modeling of diffusion with partitioning in stratum corneum using a finite element model. Ann Biomed Eng 2005;33(9):1281-92
  • Heisig M, Lieckfeldt R, Wittum G, et al. Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model. Pharm Res 1996;13(3):421-6
  • Kushner J, Deen W, Blankschtein D, et al. First-principles, structure-based transdermal transport model to evaluate lipid partition and diffusion coefficients of hydrophobic permeants solely from stratum corneum permeation experiments. J Pharm Sci 2007;96(12):3236-51
  • Wang T-F, Kasting GB, Nitsche JM. A multiphase microscopic diffusion model for stratum corneum permeability. I. formulation, solution, and illustrative results for representative compounds. J Pharm Sci 2006;95(3):620-48
  • Naegel A, Heisig M, Wittum G. Detailed modeling of skin penetration - An overview. Adv Drug Deliv Rev 2013;65(2):191-207
  • Xu G, Hughes-Oliver JM, Brooks JD, et al. Selection of appropriate training and validation set chemicals for modelling dermal permeability by U-optimal design. SAR QSAR Environ Res 2013;24(2):135-56
  • Chittenden JT, Brooks JD, Riviere JE. Development of a mixed-effect pharmacokinetic model for vehicle modulated in vitro transdermal flux of topically applied penetrants. J Pharm Sci 2014;103(3):1002-12
  • Franzen L, Windbergs M. Applications of Raman spectroscopy in skin research — From skin physiology and diagnosis up to risk assessment and dermal drug delivery. Adv Drug Delivery Rev 2015. [Epub ahead of print]
  • Hampel F, Zurich E. Is statistics too difficult? Can J Statistics 1998;26(3):497-513
  • Alves VM, Muratov E, Fourches D, et al. Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization. Toxicol Appl Pharmacol 2015;284(2):273-80
  • Sahigara F, Mansouri K, Ballabio D, et al. Comparison of Different Approaches to Define the Applicability Domain of QSAR Models. Molecules 2012;17(5):4791-810
  • National Institute for Occupational Safety and Health Education and Information. CDC - Skin - Finite Dose Skin Permeation Calculator - NIOSH Workplace Safety and Health Topic. Available from: http://www.cdc.gov/niosh/topics/skin/finiteSkinPermCalc.html [Last accessed 3 June 2015]
  • Karande P, Mitragotri S. Dependence of skin permeability on contact area. Pharm Res 2003;20(2):257-63
  • Oliveira G, Hadgraft J, Lane ME. The influence of volatile solvents on transport across model membranes and human skin. Int J Pharm 2012;435(1):38-49
  • Gajjar RM, Kasting GB. Absorption of ethanol, acetone, benzene and 1,2-dichloroethane through human skin in vitro: a test of diffusion model predictions. Toxicol Appl Pharmacol 2014;281(1):109-17
  • Scientific Consilience GmbH. DSkin 1.3. Available from: http://www.scientific-consilience.com/?q=dskin [Last accessed 3 June 2015]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.